Comments
Loading...

Quoin Pharmaceuticals

QNRXNASDAQ
Logo brought to you by Benzinga Data
$0.5220
-0.05-8.26%
At close: -
$0.5300
0.008001.53%
After Hours: 7:59 PM EDT
Consensus Rating1
Buy
Highest Price Target1
$20.00
Lowest Price Target1
$2.00
Consensus Price Target1
$8.67

Quoin Pharmaceuticals (NASDAQ:QNRX) Stock, Analyst Ratings, Price Targets, Forecasts

Quoin Pharmaceuticals Ltd has a consensus price target of $8.67 based on the ratings of 3 analysts. The high is $20 issued by Alliance Global Partners on September 7, 2022. The low is $2 issued by Ladenburg Thalmann on May 6, 2022. The 3 most-recent analyst ratings were released by Maxim Group, Alliance Global Partners, and Ladenburg Thalmann on March 15, 2024, September 7, 2022, and May 6, 2022, respectively. With an average price target of $8.67 between Maxim Group, Alliance Global Partners, and Ladenburg Thalmann, there's an implied 1535.22% upside for Quoin Pharmaceuticals Ltd from these most-recent analyst ratings.

Analyst Rating and Forecast
12345
4.0
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell

Analyst Firms Making Recommendations1

Maxim Group
Alliance Global Partners
Ladenburg Thalmann

1calculated from analyst ratings

Analyst Ratings for Quoin Pharmaceuticals

Data brought to you by Benzinga APIs

FAQ

Q

What is the target price for Quoin Pharmaceuticals (QNRX) stock?

A

The latest price target for Quoin Pharmaceuticals (NASDAQ:QNRX) was reported by Maxim Group on March 15, 2024. The analyst firm set a price target for $4.00 expecting QNRX to rise to within 12 months (a possible 654.72% upside). 1 analyst firms have reported ratings in the last year.

Q

What is the most recent analyst rating for Quoin Pharmaceuticals (QNRX)?

A

The latest analyst rating for Quoin Pharmaceuticals (NASDAQ:QNRX) was provided by Maxim Group, and Quoin Pharmaceuticals maintained their buy rating.

Q

When was the last upgrade for Quoin Pharmaceuticals (QNRX)?

A

There is no last upgrade for Quoin Pharmaceuticals

Q

When was the last downgrade for Quoin Pharmaceuticals (QNRX)?

A

There is no last downgrade for Quoin Pharmaceuticals.

Q

When is the next analyst rating going to be posted or updated for Quoin Pharmaceuticals (QNRX)?

A

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Quoin Pharmaceuticals, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Quoin Pharmaceuticals was filed on March 15, 2024 so you should expect the next rating to be made available sometime around March 15, 2025.

Q

Is the Analyst Rating Quoin Pharmaceuticals (QNRX) correct?

A

While ratings are subjective and will change, the latest Quoin Pharmaceuticals (QNRX) rating was a maintained with a price target of $15.00 to $4.00. The current price Quoin Pharmaceuticals (QNRX) is trading at is $0.53, which is out of the analyst’s predicted range.

Browse analyst ratings and price targets on all stocks.

People Also Watch